Free Trial
→ “You all just got a lot richer” (From Brownstone Research) (Ad)
OTCMKTS:BIOQ

Bioqual 9/20/2023 Earnings Report

Bioqual logo
$45.00 0.00 (0.00%)
As of 05/30/2025
ProfileEarnings History

Bioqual EPS Results

Actual EPS
-$0.79
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bioqual Revenue Results

Actual Revenue
$16.07 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bioqual Announcement Details

Quarter
Date
9/20/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Bioqual Earnings Headlines

BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company
April 30, 2025 | businesswire.com
BIOQUAL Announces Retirement of Mike O'Flaherty From Board
April 24, 2025 | businesswire.com
“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
June 1, 2025 | Brownstone Research (Ad)
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2025
April 11, 2025 | finance.yahoo.com
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2025
January 21, 2025 | finance.yahoo.com
BIOQUAL Announces Changes to Board of Directors
January 14, 2025 | finance.yahoo.com
See More Bioqual Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bioqual? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioqual and other key companies, straight to your email.

About Bioqual

Bioqual (OTCMKTS:BIOQ) provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

View Bioqual Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles